Cohort Studymoderate evidence
Biomarker for craving and acamprosate treatment response in patients with alcohol use disorder: insights from multi-omics.
Molecular psychiatry·July 1, 2026·PMID 41741704
Why it mattersIdentifies the first objective biochemical markers tied to alcohol craving and acamprosate response, offering potential tools for risk stratification and personalized treatment in addiction medicine.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled